TEL AVIV SOURASKY MEDICAL CENTER
🇮🇱Israel
- Country
- 🇮🇱Israel
- Ownership
- Private
- Established
- 1961-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.tasmc.org.il
Clinical Trials
541
Active:5
Completed:87
Trial Phases
6 Phases
Early Phase 1:5
Phase 1:16
Phase 2:42
+3 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (376 trials with phase data)• Click on a phase to view related trials
Not Applicable
250 (66.5%)Phase 2
42 (11.2%)Phase 3
32 (8.5%)Phase 4
31 (8.2%)Phase 1
16 (4.3%)Early Phase 1
5 (1.3%)Comparing the Effects of Sublingual Estradiol Treatment Versus Oral Estradiol With Cyproterone Acetate (CPA) Treatment on The Coagulation System in Transgender Women: A Prospective, Controlled Cohort Study
Not Applicable
Completed
- Conditions
- Gender Dysphoria, AdultBlood CoagulationCoagulation FactorsTransgender Persons, M01.777.500HemostasisTransgender Women
- Interventions
- Drug: Cyproterone Acetate (Androcur, BAY94-8367)
- First Posted Date
- 2025-08-28
- Last Posted Date
- 2025-08-28
- Lead Sponsor
- Tel-Aviv Sourasky Medical Center
- Target Recruit Count
- 30
- Registration Number
- NCT07145281
- Locations
- 🇮🇱
Tel Aviv Sourasky Medical Center - Institute of Endocrinology, Metabolism and Hypertension, Tel Aviv, Israel
Improving Adherence to COPD Treatments in Primary Care
Not Applicable
Not yet recruiting
- Conditions
- COPD (Chronic Obstructive Pulmonary Disease)Adherence to Care
- First Posted Date
- 2025-08-05
- Last Posted Date
- 2025-08-05
- Lead Sponsor
- Tel-Aviv Sourasky Medical Center
- Target Recruit Count
- 40
- Registration Number
- NCT07104136
- Locations
- 🇮🇱
Clalit health services, Tel Aviv, Israel
Plant vs Animal-based Protein Sources as an Anabolic and Metabolic-protective Options for SO in Older Adults
Not Applicable
Not yet recruiting
- Conditions
- Sarcopenic ObesityObesity and Obesity-related Medical ConditionsObesity (Body Mass Index >30 kg/m2)SarcopeniaMuscle LossAging
- First Posted Date
- 2025-06-22
- Last Posted Date
- 2025-06-22
- Lead Sponsor
- Tel-Aviv Sourasky Medical Center
- Target Recruit Count
- 180
- Registration Number
- NCT07030738
- Locations
- 🇮🇱
Tel Aviv Sourasky Medical Center, Tel Aviv, Israel
Early Beta Blocker Administration in STEMI Patients With SCAI B Status
Not Applicable
Recruiting
- Conditions
- ST Segment Elevation Myocardial Infarction (STEMI)Cardiogenic Shock Post Myocardial Infarction
- Interventions
- Drug: Plcacebo
- First Posted Date
- 2025-05-13
- Last Posted Date
- 2025-05-28
- Lead Sponsor
- Tel-Aviv Sourasky Medical Center
- Target Recruit Count
- 200
- Registration Number
- NCT06967194
- Locations
- 🇮🇱
Tel Aviv Sourasky Medical center, Tel Aviv, Israel
Evaluation of Fentanyl Transdermal Patch Absorption in Hemodynamically Unstable ICU Patients.
- First Posted Date
- 2025-05-13
- Last Posted Date
- 2025-05-13
- Lead Sponsor
- Tel-Aviv Sourasky Medical Center
- Target Recruit Count
- 40
- Registration Number
- NCT06966869
- Locations
- 🇮🇱
Tel Aviv Medical Center, Tel Aviv, Israel
- Prev
- 1
- 2
- 3
- 4
- 5
- 108
- Next
News
No news found